Hormone replacement therapy (HRT) using formulas in subcutaneously implantable pellet form is an alternative to hormone therapy by injection or oral ingestion.

NOTE: This policy is specifically related to testosterone pellet implantation for androgen deficiency in males. It does not apply to those undergoing treatments ...

8 авг. 2024 г. · A. Coverage of the requested drug is provided when all the following are met: a. FDA approved age b. Diagnosis of male hypogonadism.

**NOTE: Hormone pellet implantation (e.g., testosterone pellets) is considered investigational for hormone replacement therapy to treat menopause related ...

Implantable hormone pellets (testosterone) meet member benefit certificate primary coverage criteria that there be scientific evidence of effectiveness for use ...

1 авг. 2023 г. · BCBS generally covers both estrogen and testosterone hormone replacement therapy. Estrogen therapy is often prescribed to women experiencing ...

Use of Testopel® subcutaneous testosterone pellets may be considered MEDICALLY NECESSARY AND APPROPRIATE for testosterone therapy in individuals undergoing ...

3 авг. 2020 г. · This policy only addresses testosterone replacement therapy; it does ... The responsibility for the content of Blue Cross Blue Shield of Louisiana ...

5 сент. 2023 г. · Compounded testosterone products are not covered by this policy. ... © 2024 Credence is an independent licensee of the Blue Cross and Blue Shield ...

All requests for testosterone pellets (Testopel®) must be sent for clinical review and receive authorization prior to drug administration or claim payment.